https://www.selleckchem.com/pr....oducts/folinic-acid.
high-risk patients. FUNDING European Union Seventh Framework Programme. BACKGROUND The timepoint at which fetal growth begins to differ by maternal glycaemic status is not well understood. To address this lack of data, we examined gestational diabetes, impaired glucose tolerance, and early pregnancy glucose concentrations in relation to fetal growth trajectories. METHODS This cohort study included 2458 pregnant women from the NICHD Fetal Growth Studies-Singletons study, which took place between 2009 and 2013. Women were recruited f
Like
Comment
Share
